Abstract:BackgroundLoratadine is a commonly used selective non-sedating antihistaminic drug. Desloratadine is the active metabolite of loratadine and, in addition, a potential impurity in loratadine bulk powder stated by the United States Pharmacopeia as a related substance of loratadine. Published methods for the determination of both analytes suffer from limited throughput due to the time-consuming steps and tedious extraction procedures needed for the analysis of biological samples. Therefore, there is a strong demand to develop a simple rapid and sensitive analytical method that can detect and quantitate both analytes in pharmaceutical preparations and biological fluids without prior sample extraction steps.ResultsA highly-sensitive and time-saving micellar liquid chromatographic method is developed for the simultaneous determination of loratadine and desloratadine. The proposed method is the first analytical method for the determination of this mixture using a monolithic column with a mobile phase composed of 0.15 M sodium dodecyl sulfate, 10% n-Butanol and 0.3% triethylamine in 0.02 M phosphoric acid, adjusted to pH 3.5 and pumped at a flow rate of 1.2 mL/min. The eluted analytes are monitored with fluorescence detection at 440 nm after excitation at 280 nm. The developed method is linear over the concentration range of 20.0–200.0 ng/mL for both analytes. The method detection limits are 15.0 and 13.0 ng/mL and the limits of quantification are 20.0 and 18.0 ng/mL for loratadine and desloratadine, respectively. Validation of the developed method reveals an accuracy of higher than 97% and intra- and inter-day precisions with relative standard deviations not exceeding 2%.ConclusionsThe method can be successfully applied to the determination of both analytes in various matrices including pharmaceutical preparations, human urine, plasma and breast milk samples with a run-time of less than 5 min and without prior extraction procedures. The method is ideally suited for use in quality control laboratories. Moreover, it could be a simple time-saving alternative to the official pharmacopeial method for testing desloratadine as a potential impurity in loratadine bulk powder.Graphical abstractTypical chromatogram of loratadine and its major metabolite desloratadine using the proposed micellar HPLC method

[Study on determination of desloratadine in human serum and its pharmacokinetics by HPLC/MS].

[Determination of Desloratadine and Its Metabolite 3-OH Desloratadine in Human Plasma by LC-MS/MS].

Simultaneous determination of desloratadine and its active metabolite 3-hydroxydesloratadine in human plasma by LC/MS/MS and its application to pharmacokinetics and bioequivalence.

Simultaneous Determination of Rupatadine and Its Metabolite Desloratadine in Human Plasma by a Sensitive LC–MS/MS Method: Application to the Pharmacokinetic Study in Healthy Chinese Volunteers

Determination of Loratadine in Human Plasma by High Performance Liquid Chromatography-Electrospray Mass Spectrometry and Studies on Its Pharmacokinetics and Relative Bioavailability

Quantitative determination of loratadine in human plasma using liquid chromatography-electron ionization mass spectrometry and studies on its pharmacokinetics

Determination of Loratadine in Human Plasma by HPLC with Fluorescence Detector and Study on Its Bioavailability.

Prevalence of Desloratadine Slow-metabolizer Phenotype and Food-dependent Pharmacokinetics of Desloratadine in Healthy Chinese Volunteers

Study of Pharmacokinetics and Relative Bioavailability of Loratadine Tablets by HPLC- MS Method

Determination of loratadine in human plasma by a sensitive HPLC method and evaluation of its bioavailability

Synchronization of extraction and chromatographic conditions of diverse physicochemical behavior of pseudoephedrine, loratadine and desloratadine for their simultaneous determination in human plasma: Application to pharmacokinetic study

A Validated Hplc-Esi-Ms Method for the Determination of Loratadine in Human Plasma and Its Application to Pharmacokinetic Studies

Rapid micellar HPLC analysis of loratadine and its major metabolite desloratadine in nano-concentration range using monolithic column and fluorometric detection: application to pharmaceuticals and biological fluids

Simultaneous Determination of Loratadine and Its Metabolite Desloratadine in Beagle Plasma by LC-MS/MS and Application for Pharmacokinetics Study of Loratadine Tablets and Omeprazole‑Induced Drug-Drug Interaction

Pharmacokinetics and Tissue Distribution of Loratadine, Desloratadine and Their Active Metabolites in Rat Based on a Newly Developed LC-MS/MS Analytical Method.

Determination of Loratadine and Its Active Metabolite in Plasma by LC/MS/MS: an Adapted Method for Children

Determination of Levocetirizine in Human Serum by HPLC and Study on Its Pharmacokinetics

Simultaneous Analysis and Pharmacokinetics of Plasma Loratadine and Pseudoephedrine by LC-MS

A Randomized Study on the Bioequivalence of Desloratadine in Healthy Chinese Subjects and the Association of Different Metabolic Phenotypes With UGT2B10 and CYP2C8 Genotypes

Determination of Essential Components of Compound of Loratadine, Paracetamol and Pseudoephedrine by Liquid Chromatography-Tandem Spectrometry and Its Pharmacokinetics

Simultaneous Determination of Loratadine and Pseudoephedrine Sulfate in Human Plasma by Liquid Chromatography-Electrospray Mass Spectrometry for Pharmacokinetic Studies.